MGN-4220

N/A

Report date: 2024/02/21 17:01:13
NME

Base Information

Drug NameMGN-4220
Drug Alias NameMGN-4220
ClassificationSmall molecules
Mechanisms of ActionMicroRNA 29 inhibitors
TargetsMicroRNA 29
Therapy Area/IndicationsEndomyocardial Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViridian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViridian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEndomyocardial Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A